The global bone cement delivery systems market is on the brink of substantial expansion, reveals the latest analysis from Future Market Insights (FMI). Valued at USD 830 million in 2022, the market is primed to showcase a robust Compound Annual Growth Rate (CAGR) of 6.9% from 2022 to hit USD 1730 million by 2032.
One of the primary drivers propelling this upward trajectory is the escalating prevalence of osteoporotic fractures, a phenomenon observed worldwide. As osteoporosis incidence rises, there is a parallel surge in demand for bone cement delivery systems, which are integral to orthopedic musculoskeletal surgical procedures.
These procedures encompass a broad spectrum of conditions, including osteoarthritis, traumatic arthritis, osteoporosis, vascular necrosis, rheumatoid arthritis, collagen disease, and revision of previous arthroplasty. The versatility and effectiveness of bone cement delivery systems position them as indispensable tools in modern orthopedic surgery, meeting the evolving needs of patients and healthcare providers alike.
Report Sample Comprehensive Insights: https://www.futuremarketinsights.com/reports/sample/rep-gb-9653
“While bone cement has long been regarded as the gold standard in joint replacement surgery, its usage has somewhat diminished with the advent of press-fit implants,” noted FMI. “However, recent advancements have addressed the inadequacies, side effects, and toxicity associated with bone cement, leading to renewed acceptance and adoption within the orthopedic community.”
The escalating prevalence of osteoporosis, with nearly 8.9 million osteoporotic fractures occurring worldwide, is a significant driver augmenting the demand for bone cement delivery systems. Studies by the International Osteoporosis Foundation reveal that over 200 million individuals globally suffer from osteoporosis, with approximately 8.9 million fractures attributed to the condition annually, further fueling the market’s expansion.
Moreover, the rising number of knee and hip replacements adds impetus to the growth of the bone cement delivery systems market. In the United States alone, hip replacement surgeries have surged to 572,000, with knee replacements projected to reach 3.5 million by 2030.
The burgeoning demand for bone cement delivery systems underscores the critical role they play in enhancing patient outcomes and improving the efficacy of orthopedic procedures. As technological advancements continue to address existing challenges, the market is poised to witness sustained growth in the coming years.
Key Takeaways: Bone Cement Delivery Systems Market (2022-2032)
- The bone cement delivery systems market is thriving, driven by a rise in joint replacement surgeries and the aging population.
- The market is expected to reach a value of USD 1730 million by 2032, reflecting a steady Compound Annual Growth Rate (CAGR) of 6.9%.
- Bone cement delivery systems play a vital role in orthopedic surgeries by ensuring implant stability and optimizing load-bearing capacity.
- The rising prevalence of osteoporosis and related fractures among the elderly is a key driver for market growth.
- Development of new technologies like antibiotic-loaded bone cements and minimally invasive delivery systems are further propelling market expansion.
- North America currently dominates the market, but Asia Pacific is expected to witness significant growth due to factors like improving healthcare infrastructure and rising awareness about joint replacement surgeries.
- The market is competitive, with a focus on research and development of improved delivery systems to gain an edge.
Overall, the bone cement delivery systems market is poised for significant growth due to rising demand for orthopedic procedures and continuous advancements in technology.
Get Customization on This Report: https://www.futuremarketinsights.com/customization-available/rep-gb-9653
Bone Cement Delivery Systems Market Competition:
In the global market for Bone Cement Delivery Systems, leading companies include BD, Stryker Corporation, 3M, Cardinal Health, Entellus Medical, Johnson & Johnson Services, Inc., Medtronic PLC, Smith & Nephew plc, IZI Medical Products, and Synimed.
Stryker’s AutoPlex mixer and delivery system offer remarkable speed and convenience. With just a simple button press, the device swiftly mixes and transfers high-viscosity bone cement for delivery in under 60 seconds. Its automated blade, driven by a mixing chamber, ensures consistent blending of components, eliminating human error and variability.
Key Segmentation:
By Cement Type
- Calcium Phosphate
- Polymethyl Methacrylate
- Others
By Surgery Type
- Knee Arthroplasty
- Hip Arthroplasty
- Kyphoplasty
- Vertebroplasty
- Others
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa
Request Purchase Now: https://www.futuremarketinsights.com/checkout/9653
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube